We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Older Blood Riskier in Heart Surgery Transfusions

By HospiMedica staff writers
Posted on 12 Jul 2006
Blood used in transfusions closer to the 42-day maximum may be less healthy than fresher blood, according to a new study.

Researchers from Duke University Medical Center (Durham, NC, USA) took a retrospective look at the medical files of 321 patients who underwent repeat, open-heart surgeries for either coronary artery bypass or valve replacement between 1995 and 2001. More...
The patients received a relatively large amount of donated blood--an average of five units--during these procedures. The researchers tracked the patients' incidence of in-hospital and long-term mortality, as well as post-surgical complications such as kidney failure. They compared the rate of those types of outcomes with the number of units and age of the blood each patient received.

In-hospital death rates rose along with the age of blood received. Specifically, repeat bypass patients who received the freshest blood during their operation (stored for one to 19 days) had a 4% in-hospital death rate, compared to a 25% rate in similar patients receiving the oldest blood (stored for 31 to 42 days). Another finding was the rise in hospital length-of-stay: an average of 3.5 days for those receiving freshest blood in comparison to seven days for those getting older units. Patients who received older blood also had higher rates of death in the eight years after their surgery, the researchers noted. The study was published in the July 2006 issue of Analgesia & Anesthesia

"One of the theories is that as red blood cells age during storage, they become stiffer,” said lead investigator Dr. Elliot Bennett-Guerrero, director of perioperative clinical research at Duke University. "There's lots of evidence that these stiffer red blood cells may not deliver oxygen as efficiently. Or, they may even clot up or get stuck in organs and cause those organs to become damaged.”

U.S. Food and Drug Administration (FDA) regulations prohibit the use of blood stored for more than 42 days.



Related Links:
Duke University Medical Center

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.